With our specialized know-how in ophthalmology, microtechnology, and information technology, we focus our research and development efforts as well as our commercial operations on ophthalmic surgery (refractive, cataract and glaucoma) and on ocular diagnostics (glaucoma and refractive/cornea).
We actively pursue partnerships, alliances and acquisitions that ensure our innovations reach eye care providers and patients quickly. For example, the worldwide and exclusive marketing alliance with AMO from 1999 until 2006 has been a key factor in the rapid build-up of our significant share in the microkeratome market for refractive surgery, and of a major international presence in ophthalmology markets.
